Plexin-B3 expression stimulates MET signaling, breast cancer stem cell specification, and lung metastasis

Qiaozhu Zuo, Yongkang Yang, Yajing Lyu, Chen Yang, Chelsey Chen, Shaima Salman, Tina Yi Ting Huang, Elizabeth E. Wicks, Walter Jackson, Emmanuel Datan, Wenxin Qin, Gregg L. Semenza

Research output: Contribution to journalArticlepeer-review

Abstract

Intratumoral hypoxia is a microenvironmental feature that promotes breast cancer progression and is associated with cancer mortality. Plexin B3 (PLXNB3) is highly expressed in estrogen receptor-negative breast cancer, but the underlying mechanisms and consequences have not been thoroughly investigated. Here, we report that PLXNB3 expression is increased in response to hypoxia and that PLXNB3 is a direct target gene of hypoxia-inducible factor 1 (HIF-1) in human breast cancer cells. PLXNB3 expression is correlated with HIF-1α immunohistochemistry, breast cancer grade and stage, and patient mortality. Mechanistically, PLXNB3 is required for hypoxia-induced MET/SRC/focal adhesion kinase (FAK) and MET/SRC/STAT3/NANOG signaling as well as hypoxia-induced breast cancer cell migration, invasion, and cancer stem cell specification. PLXNB3 knockdown impairs tumor formation and lung metastasis in orthotopic breast cancer mouse models.

Original languageEnglish (US)
Article number112164
JournalCell Reports
Volume42
Issue number3
DOIs
StatePublished - Mar 28 2023

Keywords

  • CP: Cancer
  • HIF-1
  • MET
  • Plexin-B3
  • cancer stem cells
  • focal adhesion kinase
  • hypoxia
  • invasion
  • metastasis
  • migration
  • tumor microenvironment

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Plexin-B3 expression stimulates MET signaling, breast cancer stem cell specification, and lung metastasis'. Together they form a unique fingerprint.

Cite this